| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/31/2008 | US20080027066 Arylpiperazinyl Compounds |
| 01/31/2008 | US20080027065 G protein coupled receptor inhibitors (Gpr38) such as 6-[(4-fluorophenyl)oxy]-N-methyl-N-(4-{[(3S)-3-methyl-1-piperazinyl]methyl}phenyl)-3-pyridinecarboxamide for treatment of gastric stasis in an enterally fed patient |
| 01/31/2008 | US20080027064 imidazo[1,5-a]pyrido[3,2-e]pyrazines; neurologic and psychiatric disorders, for example psychosis |
| 01/31/2008 | US20080027063 Imidazopyrazines as protein kinase inhibitors |
| 01/31/2008 | US20080027062 2-amino-4-N-cyclohexylmethylamino-6-(L-erythro-1,2-dihydroxypropyl)-7,8-dihydro-pteridine; treatment of pathological blood pressure decreases, such as occur in septic or hemorrhagic shock, in tumor or cancer therapy with cytokines, liver cirrhosis; ulcerative colitis; NO synthase inhibitor |
| 01/31/2008 | US20080027061 omega-Carboxy Aryl Substituted Diphenyl Ureas As p38 Kinase Inhibitors |
| 01/31/2008 | US20080027060 Dipeptide nitriles |
| 01/31/2008 | US20080027059 Substituted isoxazolines, pharmaceutical compositions containing same, methods of preparing same, and uses of same |
| 01/31/2008 | US20080027058 Mitotic Kinesin Inhibitors |
| 01/31/2008 | US20080027057 Use of dihydroimidazolones for the treatment of dogs |
| 01/31/2008 | US20080027056 Substituted heterocyclic ethers and their use in cns disorders |
| 01/31/2008 | US20080027055 1-Substituted indoles, and benzimidazoles additionally substituted with an amino ligand, e.g., 1-[(5-chlorothien-2-yl)sulfonyl]-5-[2-(piperidin-1-yl)ethoxy]-1H-indole; treating schizophrenia, depression, attention deficit disorder, Alzheimer's disease and Parkinson's disease |
| 01/31/2008 | US20080027054 4-Substituted quinolines as antitumor agents |
| 01/31/2008 | US20080027053 Antimicrobial oxazolidinone prodrugs |
| 01/31/2008 | US20080027052 Methods for treating cystic kidney disease |
| 01/31/2008 | US20080027051 Novel Heteroaryl Substituted Benzoxazoles |
| 01/31/2008 | US20080027050 Heterocyclic Amide Compound and Use Thereof as an Mmp-13 Inhibitor(Amended Ex Officio) |
| 01/31/2008 | US20080027049 Benzofurans as potassium ion channel modulators |
| 01/31/2008 | US20080027048 2-Phenylthiophene Derivative |
| 01/31/2008 | US20080027047 Compounds that modulate HSP90 activity and methods for identifying same |
| 01/31/2008 | US20080027045 2,4-Pyrimidinediamine Compounds And Uses As Anti-Proliferative Agents |
| 01/31/2008 | US20080027044 Prodrug antibiotic screens |
| 01/31/2008 | US20080027043 Preparation of antimicrobial formulations using 7-oxa-2-thia-1,5-diazabicyclo[3.3.1]nonane-2,2-dione |
| 01/31/2008 | US20080027042 Novel Aminopyridine Derivatives Having Aurora a Selective Inhibitory Action |
| 01/31/2008 | US20080027041 Pyridizinone derivatives |
| 01/31/2008 | US20080027040 Oxazolidinone-Quinolone Hybrid Antibiotics |
| 01/31/2008 | US20080027039 e.g. N-methyl-{1-[1-(2-fluorophenethyl)piperidin-4-yl]-1H-indol-6-yl}acetamide having serotonin receptor antagonist activity; olanzapine, risperidone, perospirone, quetiapine, clocapramine, carpipramine, mosapramine, chlorpromazine,levomeromazine, trazodone, imipramine, paroxetine, fluoxamine etc |
| 01/31/2008 | US20080027038 N-Acylated lipophilic amino acid derivatives |
| 01/31/2008 | US20080027037 Cyclic compounds |
| 01/31/2008 | US20080027036 S1P receptor modulating compounds and use thereof |
| 01/31/2008 | US20080027035 Dpp-Iv Inhibitors |
| 01/31/2008 | US20080027034 Ciclesonide and Syk Inhibitor Combination and Method of Use Thereof |
| 01/31/2008 | US20080027033 Method and Composition for Treatment of Cutaneous Lesions |
| 01/31/2008 | US20080027032 Combinations comprising cox-2 inhibitors and aspirin |
| 01/31/2008 | US20080027031 Retinoids and Related Compounds for the Treatment of Neuroinflammatory Conditions, Diseases and Disorders |
| 01/31/2008 | US20080027030 Pharmaceutical compositions comprising amifostine and related compounds |
| 01/31/2008 | US20080027029 Cold menthol receptor-1 antagonists |
| 01/31/2008 | US20080027028 Novel ketopyrrole intermediates from which may be derived a novel class of organic iridium compounds which are shown to be useful in organic electroluminescent devices; (bis(trimethylsilyloxy)-2,4,6-trideuterio benzoyl)-3,4,5-trideuteriopyrrole, for example |
| 01/31/2008 | US20080027027 Lactosucrose High Content Saccharide, Its Preparation and Uses |
| 01/31/2008 | US20080027026 such as acne, eczema, shingles, insect bites and hives via cream or ointment containing hydroxypropyl methylcellulose acetate succinate ("HPMCAS") in micronized form |
| 01/31/2008 | US20080027025 Protection From And Treatment Of Prion Protein Infection |
| 01/31/2008 | US20080027024 Dietary supplement and methods of use |
| 01/31/2008 | US20080027023 Antiproliferative Compositions Comprising Aryl Substituted Xylopyranoside Derivatives |
| 01/31/2008 | US20080027022 Method to treat gastric lesions |
| 01/31/2008 | US20080027021 Use of cpg oligodeoxynucleotides to induce angiogenesis |
| 01/31/2008 | US20080027020 Human Neuropeptide Receptor |
| 01/31/2008 | US20080027019 Oligonucleotide compositions and methods for the modulation of the expression of b7 protein |
| 01/31/2008 | US20080027015 Methods and Materials for Modulating Enac-Beta |
| 01/31/2008 | US20080027014 Novel SGLT inhibitors |
| 01/31/2008 | US20080027013 Antibacterial treatment of osteoarthritis |
| 01/31/2008 | US20080027012 Bridged carbamate macrolides |
| 01/31/2008 | US20080027011 Homogeneous paste and gel formulations |
| 01/31/2008 | US20080027010 Treatment of refractory cancers using Na+/K+-ATPase inhibitors |
| 01/31/2008 | US20080027009 Surfactant Preparation Having Reduced Enzyme Damaging |
| 01/31/2008 | US20080027004 Phosphorylated COP1 molecules and uses thereof |
| 01/31/2008 | US20080027002 Compositions and methods for targeting cancer-specific transcription complexes |
| 01/31/2008 | US20080026997 Medicament for the Treatment of Fungal Infections Particularly Aspergillosis |
| 01/31/2008 | US20080026991 Compositions containing quaternary ammonium compounds |
| 01/31/2008 | US20080026990 18-Membered Nitrobenzyl- and Aminobenzyl-Substituted Cyclohexadepsipeptides for Controlling Endoparasites and a Process for Their Preparation |
| 01/31/2008 | US20080026987 Use of Liver-Selective Glucokinase Activators |
| 01/31/2008 | US20080026986 Reversal of the suppressive function of specific t cells via toll-like receptor 8 signaling |
| 01/31/2008 | US20080026985 Control of gene expression |
| 01/31/2008 | US20080026984 Methods for treating inflammatory disease by administering aldehydes and derivatives thereof |
| 01/31/2008 | US20080026983 Compositions and methods for alleviating joint pain and improving joint flexibility |
| 01/31/2008 | US20080026981 Pharmaceutical Compositions |
| 01/31/2008 | US20080026943 Phenyl-Substituted [1,2]-Oxazine-3,5-Dione and Dihydropyrone Derivatives |
| 01/31/2008 | US20080026399 treating bladder and lower urinary tract syndromes particularly irrative symptoms using alpha 1d-adrenergic receptor ( alpha 1dAR) antagonists; drug screening |
| 01/31/2008 | US20080026087 Litchi Sinensis Extracts Containing Oligomeric Proanthocyanidins and Processes of Making Thereof |
| 01/31/2008 | US20080026086 Synergistic Neuroprotective, Combinations Of Flavanols, Hydroxystilbenes, Flavanones, Flavones, Flavonols, Proanthocyanidins And Anthocyanidins |
| 01/31/2008 | US20080026082 Erectyle disfunction phyto-nutraceutical synergistic composition |
| 01/31/2008 | US20080026081 Methods of Treatment Using (+)-Isopropyl 2-Ethoxyethyl-4-(2-Chloro-3-Cyano-Phenyl)-1,4-Dihydro-2,6-Dimethyl-Pyridine-3,5-Dicarboxylate |
| 01/31/2008 | US20080026080 Reacting a gluconic acid with lactic acid in the presence of calcium hydroxide and water to obtain a calcium gluconolactate molecule having the formula HO-CH2-(CHOH)4-COO-Ca-OOC-CH(-OH)-CH3 with molecular weight of 324.2994; physical and chemical properties; nutraceuticals |
| 01/31/2008 | US20080026078 Nasal composition |
| 01/31/2008 | US20080026077 Methods and compositions of gene delivery agents for systemic and local therapy |
| 01/31/2008 | US20080026076 Quercetin supplementation to treat hypertension |
| 01/31/2008 | US20080026075 Constitutional Function-Improving Agents |
| 01/31/2008 | US20080026074 Method of short term skin wrinkles correction using strontium divalent ion |
| 01/31/2008 | US20080026072 glycoproteins having alpha 1,4-linked N-acetylglucosamine residue from milk of mammal containing carrier polypeptide with alpha 1,4-N-acetylglucosaminyl transferase; for treatment or prevention of gastric ulcers |
| 01/31/2008 | US20080026070 Pharmaceutical formulations for the prolonged release of active principle(s), and their applications, especially therapeutic applications |
| 01/31/2008 | US20080026067 Method for Increasing Specific Surface Area of Slightly Soluble Drug |
| 01/31/2008 | US20080026065 Powdered Compositions Of Sensitive Active Materials In An At Least Partially Amorphous State |
| 01/31/2008 | US20080026064 Cell-polymer fiber compositions and uses thereof |
| 01/31/2008 | US20080026063 Composition containing reduced coenzyme Q10 and production method thereof |
| 01/31/2008 | US20080026061 Crystalline N-(4-chloro-3-methyl-5-isoxazolyl)-2-[2-methyl-4.5-(methylenedioxy)phenylacetyl]-thiophene-3-sulfonamide |
| 01/31/2008 | US20080026060 Controlled-release pharmaceutical tablets |
| 01/31/2008 | US20080026059 Methods of Reducing Degradant Formation in Pharmaceutical Compositions of Varenicline |
| 01/31/2008 | US20080026058 Methods for treating and preventing mucositis |
| 01/31/2008 | US20080026057 Process for the Preparation of a Solid, Orally Administrable Pharmaceutical Composition |
| 01/31/2008 | US20080026056 Antibiotic-Based Pharmaceutical Formulation in Microcapsular Form |
| 01/31/2008 | US20080026055 Chewable tablet containing phenylephrine |
| 01/31/2008 | US20080026054 Novel anelgesic combination |
| 01/31/2008 | US20080026052 Oral Dosage Forms with Therapeutically Active Agents In Controlled Release Cores and Immediate Release Gelatin Capsule Coats |
| 01/31/2008 | US20080026050 Solid dose formulations of a thrombin receptor antagonist |
| 01/31/2008 | US20080026049 Liposomal compositions for parenteral delivery of agents |
| 01/31/2008 | US20080026047 Cancer Detection Reagents And Uses In Pathology And Diagnostics And Cancer Cell Death |
| 01/31/2008 | US20080026045 Combination Chemotherapy Comprising a Gemcitabine and a Liposomal Platium Complex |
| 01/31/2008 | US20080026044 Combination Chemotherapy Comprising Capecitabine and a Liposomal Platinum Complex |
| 01/31/2008 | US20080026042 Preoperative Treatment of Post Operative Pain |
| 01/31/2008 | US20080026040 Active agent-releasing dosage forms |
| 01/31/2008 | US20080026039 Benzoyl peroxide pads and formulations therefor |